Ann: PARs drug reduces cartilage degradation in subjects with OA, page-151

Remember there are plenty of heavily leveraged traders out there who see PAR purely as a trade play.

They couldn’t give a fig about the COMPANY or its iPPS results, NRL players, multi joint pain reduction, the list goes on.

The price swing yesterday was in was in no way whatsoever a non endorsement or slap for the company , it’s current results or its future medical advancements. It was pure and simple a very very short term trading move.

Watch the price jump in the near term with traders exiting and investors adding with the company continuing to advance through the various FDA requirements. The future price gains will match this advancement.